1. Volume 62, Issue 3, Pages 507-514 (September 2012)
Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study) 
Douglas G. Tincello, Sara Kenyon, Keith R. Abrams, Christopher Mayne, Philip Toozs-Hobson, David Taylor, Mark Slack 
European Urology 
Volume 62, Issue 3, Pages (September 2012)
DOI: /j.eururo
Copyright © 2012 European Association of Urology Terms and Conditions

2. Fig. 1 Consolidated Standards of Reporting Trials diagram.
DO=detrusor overactivity; ISC=intermittent self-catheterisation. Figures in square brackets are the number of women returning diary data “in window”; numbers in curved brackets are cumulative totals of number of patients lost to follow-up or withdrawn at each visit.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

3. Fig. 2 Outcome data at 6 mo. onaBoNTA=botulinum toxin A.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

4. Fig. 3 Time to patient-reported recurrence of symptoms.
onaBoNTA=botulinum toxin A.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions